How should I adjust my insulin glargine (Lantus) dose, currently 10 units in the morning and 4 units in the evening, given fasting hyperglycemia (~200 mg/dL) and pre‑lunch glucose falling to 60‑100 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adjust Your Lantus Dosing Schedule

You need to consolidate your split-dose Lantus into a single daily injection and reduce the morning dose, because your current twice-daily regimen is causing dangerous mid-day hypoglycemia while failing to control your fasting glucose.

The Core Problem

Your pattern reveals a critical dosing error: Lantus (insulin glargine) is designed as a once-daily basal insulin with a 24-hour duration of action 1. By splitting it into morning and evening doses (10 units AM + 4 units PM = 14 units total), you're creating overlapping insulin peaks that drive your glucose dangerously low by noon (60-100 mg/dL), while the morning dose wears off before the next morning, leaving you with fasting hyperglycemia around 200 mg/dL.

Immediate Action Plan

Step 1: Switch to Once-Daily Dosing

  • Stop the split dosing immediately
  • Start with 10 units once daily at bedtime (not your current total of 14 units—the morning dose was causing your noon lows) 2
  • Choose a consistent time you can maintain every day 1

Step 2: Titrate Using the Evidence-Based Algorithm

Following the 2025 ADA Standards 2:

  • Check your fasting blood glucose every morning
  • Adjust your dose every 3 days based on the average of your last 3 fasting readings:
    • If FBG ≥180 mg/dL (≥10 mmol/L): increase by 6-8 units
    • If FBG 140-179 mg/dL (7.8-9.9 mmol/L): increase by 4 units
    • If FBG 120-139 mg/dL (6.7-7.7 mmol/L): increase by 2 units
    • If FBG 100-119 mg/dL (5.6-6.6 mmol/L): increase by 0-2 units
    • If FBG <100 mg/dL (<5.6 mmol/L): no change needed
    • If any glucose reading <70 mg/dL (<4.0 mmol/L): decrease dose by 10-20% 2

Step 3: Monitor for Hypoglycemia

  • Test your blood glucose before each meal and at bedtime for the first 2 weeks 1
  • Your noon readings should normalize to 100-140 mg/dL once the overlapping morning dose is eliminated
  • If you experience any reading <70 mg/dL, reduce your Lantus dose by 2-3 units immediately 2

Why This Works

Research demonstrates that once-daily Lantus provides stable 24-hour basal coverage 3. Your twice-daily split was never indicated—studies show morning, dinner, or bedtime administration are all effective, but the key is once-daily dosing 3, 4. The morning administration in your case was stacking insulin action during mid-day when you don't need it, while leaving you uncovered during the dawn phenomenon (3 AM-8 AM) when your liver increases glucose production 5.

Critical Pitfalls to Avoid

  • Never mix or dilute Lantus with other insulins—it will not work properly 1
  • Don't be timid with dose increases—your FBG of 200 mg/dL requires aggressive titration. You'll likely need 20-30 units once daily based on typical requirements 6, 7, 8
  • Don't skip the 3-day waiting period between adjustments—insulin glargine takes 2-4 days to reach steady state
  • Rotate injection sites (abdomen, thigh, upper arm) within the same body region to prevent lipohypertrophy 1

Expected Timeline

  • Days 1-3: Your noon lows should resolve immediately once you stop the morning dose
  • Weeks 1-3: Your fasting glucose should progressively improve as you titrate upward every 3 days
  • Week 4-6: You should reach your fasting glucose goal of <100 mg/dL 2

When to Seek Help

Contact your healthcare provider immediately if:

  • You experience glucose <60 mg/dL despite dose reductions
  • Your fasting glucose remains >180 mg/dL after reaching 0.5 units/kg/day (roughly 35-40 units for most adults)
  • You develop symptoms of hyperglycemia (excessive thirst, urination, blurred vision)

Consider obtaining a glucagon emergency kit for severe hypoglycemia risk 2.

Related Questions

In a 43‑year‑old woman (56 kg, normal renal function) who stopped dexamethasone after being on insulin glargine (Lantus) 24 U at 4 pm, should the initial basal dose be 12 U or 14 U?
In a patient taking insulin glargine 10 units nightly who has a fasting glucose of 273 mg/dL, what is the next management step?
What is the initial bedtime dose of Lantus (insulin glargine) for a patient with hyperglycemia (blood sugar levels of 300-500 mg/dL)?
How should the insulin regimen be adjusted for a patient with a recent A1C of 10% who is currently on sliding‑scale insulin and insulin glargine (100 U/mL)?
A 28‑week‑gestation pregnant woman weighing 114 kg has a fasting blood glucose of 157 mg/dL while on insulin glargine (Lantus) 40 units daily; how much should the insulin glargine dose be increased?
Should a pregnant inmate with vaginal bleeding be transferred to the hospital immediately?
What are the splinting recommendations for a suspected triquetral fracture when a scaphoid fracture cannot be ruled out?
What are the recommended indications, dosing guidelines, and safety limits for pyridoxine (vitamin B6) supplementation in Canada?
What conditions does trazodone treat?
Are standard doses of vitamin C (ascorbic acid) and zinc safe for a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency?
What is the activated partial thromboplastin time (APTT), its normal range, causes of a prolonged result, and how is it used to monitor and adjust unfractionated heparin therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.